日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: Antibody-mediated thrombotic disease

社论:抗体介导的血栓性疾病

Halkidis, Konstantine; Liu, Szumam; Chaturvedi, Shruti

The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura

皮质类固醇在免疫性血栓性血小板减少性紫癜中的现代作用

Halkidis, Konstantine

What is allosteric regulation? Exploring the exceptions that prove the rule!

什么是变构调节?探索那些证明规则的例外情况!

McCullagh, Martin; Zeczycki, Tonya N; Kariyawasam, Chathuri S; Durie, Clarissa L; Halkidis, Konstantine; Fitzkee, Nicholas C; Holt, Jo M; Fenton, Aron W

Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura.

免疫性血栓性血小板减少性紫癜中多抗体与ADAMTS13结合的机制研究

Halkidis Konstantine, Meng Chan, Pillai Vikram G, Shay Madison, Liu Szumam, Zheng X Long

The history of thrombotic thrombocytopenic purpura research: a narrative review

血栓性血小板减少性紫癜研究史:叙述性综述

Halkidis, Konstantine; Lämmle, Bernhard; Zheng, X Long

ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura

ADAMTS13构象及其在免疫性血栓性血小板减少性紫癜中的抑制机制

Halkidis, Konstantine; Zheng, X Long

A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura

针对ADAMTS-13远端羧基末端的人类单克隆抗体可调节其对血栓性血小板减少性紫癜抑制剂的敏感性

Halkidis, Konstantine; Siegel, Don L; Zheng, X Long

Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.

血浆中 S100A8/A9、组蛋白/DNA 复合物和游离 DNA 的水平可预测免疫性血栓性血小板减少性紫癜的不良后果

Sui Jingrui, Lu Ruinan, Halkidis Konstantine, Kocher Nicole K, Cao Wenjing, Marques Marisa B, Zheng X Long

Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer

HIV-1 Env 受体激活导致 gp41 三聚体不对称暴露

Khasnis, Mukta D; Halkidis, Konstantine; Bhardwaj, Anshul; Root, Michael J